Gamma-butyrolactone

Gamma-butyrolactone is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 14993 references associated with Gamma-butyrolactone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Gamma-butyrolactone

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gamma-butyrolactone

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Ataxia D001259 20 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Stomach Ulcer D013276 75 associated lipids
Weight Loss D015431 56 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Total 9

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Gamma-butyrolactone

Download all related citations
Per page 10 20 50 100 | Total 3467
Authors Title Published Journal PubMed Link
pmid:6110470
Beart PM and Gundlach AL 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms. 1980 Br. J. Pharmacol. pmid:6108139
Schiff PB and Horwitz SB Taxol stabilizes microtubules in mouse fibroblast cells. 1980 Proc. Natl. Acad. Sci. U.S.A. pmid:6103535
pmid:6102920
pmid:6099268
pmid:6035
pmid:6034
pmid:591953
pmid:566319
pmid:542960
Bralet J et al. Influence of various agents on the development of brain edema in the rat following microembolism. Protective effect of gamma-butyrolactone. 1979 Nov-Dec Stroke pmid:524404
pmid:501555
pmid:456411
pmid:43241
pmid:4087925
pmid:4026540
Horinouchi S et al. The cloned Streptomyces bikiniensis A-factor determinant. 1985 J. Antibiot. pmid:4019312
Phillips ML and Bonjouklian R Cyclic platelet-activating factor analogues derived from 2-deoxy-D-erythro-pentose. 1986 Carbohydr. Res. pmid:3955572
Hidaka T et al. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug. 1985 Jpn. J. Pharmacol. pmid:3932730
pmid:3928812